SPHERA FUNDS MANAGEMENT LTD. - CARBYLAN THERAPEUTICS INC ownership

CARBYLAN THERAPEUTICS INC's ticker is CBYL and the CUSIP is 141384107. A total of 41 filers reported holding CARBYLAN THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of CARBYLAN THERAPEUTICS INC
ValueSharesWeighting
Q4 2015$1,303,000
-8.8%
360,000
-10.0%
0.19%
+4.9%
Q3 2015$1,428,000
-50.1%
400,0000.0%0.18%
-35.0%
Q2 2015$2,860,000400,0000.28%
Other shareholders
CARBYLAN THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Broadfin Capital, LLC 1,178,941$8,429,0000.45%
SPHERA FUNDS MANAGEMENT LTD. 400,000$2,860,0000.28%
PURA VIDA INVESTMENTS, LLC 40,000$276,0000.14%
Omega Advisors Inc. 100,000$715,0000.01%
PUTNAM INVESTMENTS LLC 634,780$4,539,0000.01%
Pentwater Capital Management LP 225,000$1,609,0000.01%
Alyeska Investment Group, L.P. 199,736$1,428,0000.01%
PANAGORA ASSET MANAGEMENT INC 207,158$1,481,0000.01%
FRANKLIN RESOURCES INC 1,524,100$10,897,0000.01%
PRICE T ROWE ASSOCIATES INC /MD/ 2,803,300$20,044,0000.00%
View complete list of CARBYLAN THERAPEUTICS INC shareholders